精子数量检测市场报告：2031 年趋势、预测与竞争分析

全球精子数量检测市场前景光明，生育治疗中心、医院/诊所和诊断实验室市场都存在大量机会。预计到 2031 年全球精子数量检测市场规模将达到 27 亿美元，2025 年至 2031 年的复合年增长率为 4.7%。该市场的主要驱动力是家庭精子检测套组的日益普及和认知度、不孕症患者数量的不断增加以及晚婚趋势的日益增强。

• Lucintel 预测显微镜将成为预测期内成长最快的技术类别。
• 在最终用途类别中，预计生育中心在预测期内仍将是最大的部分。
• 根据地区，北美将在预测期内继续成为最大的地区。

精子数量检测市场的策略性成长机会

技术进步、对男性不孕问题日益增长的认识以及不断发展的医疗需求为精子数量测试市场创造了多种策略成长机会。利用这些机会不仅可以显着扩大市场，还能改善不孕症管理解决方案。

• 居家检测解决方案：居家精子计数选项将成为一个巨大的成长途径。这使得公司能够利用日益增长的人口寻找无需去诊所就能监测不孕不育的方法这一优势。
• 与生育治疗的整合：将精液量测试纳入更广泛的生育治疗计划还有进一步发展的空间。当与精子分析等其他诊断和治疗服务结合时，可以实现不孕症的综合治疗，从而改善患者的治疗效果。
• 人工智慧和自动化：人工智慧（AI）技术的使用和精子计数过程的自动化将带来显着的益处。诊断能力将会提高，同时测试可能会变得更加简化，这对医疗保健产业的各个相关人员来说都很重要。
• 经济实惠的检测解决方案：方便且经济的精子数量测试有可能开拓新的市场，特别是在医疗资源有限的地区。此外，透过使设备便携、易于使用和价格合理，可以满足各个人群尚未满足的需求，从而扩大市场覆盖范围。
• 教育和宣传计划：对男性不孕和精液量的教育和宣传计划的投资具有巨大的潜力。提高公众认知度并减少对男性生殖结果的耻辱感将增加对检测和相关服务的需求。

在家检测创新、人工智慧整合和综合生育治疗计划推动的精液量检测具有巨大的策略性成长机会。价格合理、便利且具教育意义的宣传活动是扩大市场占有率和满足各种生殖健康需求的关键。这些可能性将塑造精子数量测试的未来，同时激发不孕症治疗的发展。

精子数量检测市场驱动因素与挑战

精子数量检测市场受到多种技术、经济和监管因素的影响，这些因素推动了精子数量检测市场的成长，但也带来了挑战。因此，了解这些驱动因素和挑战是所有相关人员探索生殖医学诊断不断发展的领域的先决条件。

推动精子数量测试市场的因素有：

1. 技术进步：由于技术的进步，尤其是高解析度成像和人工智慧（AI）的使用等领域，精子计数测试变得更加准确。这提高了诊断的准确性并有助于识别不孕症等问题，从而增加了购买该设备的用户数量，推动了市场扩张。

2. 人们对男性不孕症的认识不断提高：人们对男性不孕症的认识不断提高，解释了寻求更频繁进行精子数量测试的人数增加的原因。此外，随着患者和医疗专业人员越来越关注男性生殖健康，对检查这种情况的先进解决方案的需求日益增加，从而刺激了市场的扩张。

3. 家庭测试解决方案：目前，家庭平台的采用正在推动可在家中私密使用的男性不孕检测套组的销售。这些产品为不孕症的临床监测提供了一种替代方案，而许多人都希望避免这种监测。

4. 与不孕症治疗相结合：这种方法允许透过精子计数测试解决一些诊断和治疗问题，作为更广泛的不孕症治疗计划的一部分。这推动了市场对全面考虑不孕不育问题的先进诊断解决方案的需求。

5. 研发投入：增加研发资金，持续促进精子数量检测技术的创新。这导致了研发支出的增加，使世界各地不同人群的精子数量水平和分析方法得到了快速提高。

精子数量检测市场面临的挑战包括：

1. 先进检测成本高：成本是影响复杂精子计数技术（如 IVF 试剂套件和 PCR）采用率的关键因素。在低度开发国家，缺乏价格合理的设备和化学品会限制获取讯息，阻碍市场渗透。

2. 监管障碍：产品核准可能受到不同地区针对医疗设备（包括诊断测试产品）的法律规范和要求的限制。遵守不同的标准可能会延迟产品的营销、註册和批准。

3. 技术整合问题：将先进的精子计数系统与现有系统整合时也会出现瓶颈。相容性问题加上特殊的培训要求，可能会使参与此类程序的医疗专业人员难以采用该系统。

推动和阻碍精子数量测试市场的关键因素反映了由技术进步、意识增强和监管复杂性所塑造的不断变化的环境。技术创新和对男性生育能力的关注推动了销售成长，而成本、法律要求和景气衰退等问题则阻碍了成长。因此，对于产业参与者来说，重要的是应对这些挑战，同时利用推动因素在不断变化的环境中取得成功，并改善生殖保健。

目录

第一章执行摘要

第 2 章全球精子数量测试市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 2019 年至 2031 年的市场趋势与预测分析

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球精子数量检测市场趋势（2019-2024）和预测（2025-2031）
• 全球精子数量检测市场（依技术分类）
  • 层析法免疫检测测定和比色反应
  • 显微镜
  • 基于智慧型手机
  • 其他的
• 全球精子数量检测市场依年龄层划分
  • 34岁或以下34岁
  • 35-40岁
  • 年龄 41 岁或以上
• 全球精子数量检测市场（依最终用途划分）
  • 不孕不孕治疗中心
  • 医院和诊所
  • 诊断实验室
  • 其他的

第 4 章 2019 年至 2031 年各地区的市场趋势与预测分析

• 全球精子数量检测市场（按地区划分）
• 北美精子数量检测市场
• 欧洲精子数量检测市场
• 亚太地区精子数量检测市场
• 世界其他地区的精子数量检测市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球精子数量检测市场成长机会（依技术划分）
  • 全球精子数量检测市场成长机会（依年龄层划分）
  • 全球精子数量检测市场的成长机会（以最终用途划分）
  • 全球精子数量检测市场成长机会（按地区划分）
• 全球精子数量检测市场的新趋势
• 战略分析
  • 新产品开发
  • 全球精子数量检测市场产能扩大
  • 全球精子数量检测市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业简介

• AB ANALITICA
• Artron Laboratories
• Bioline Technologies
• CooperSurgical
• Diacron International
• DNA Diagnostics Center
• ExSeed Health
• Hamilton Thorne
• Medical Electronic Systems
• Microptic

The future of the global sperm count test market looks promising with opportunities in the fertility center, hospital & clinic, and diagnostic laboratory markets. The global sperm count test market is expected to reach an estimated $2.7 billion by 2031 with a CAGR of 4.7% from 2025 to 2031. The major drivers for this market are the rising accessibility and awareness of home-based sperm test kits, growing rates of infertility cases, and the expanding trend of late parenthood.

• Lucintel forecasts that, within the technique category, microscopy is expected to witness the highest growth over the forecast period.
• Within the end-use category, fertility center will remain the largest segment over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Sperm Count Test Market

Current trends in relation to sperm count test examination show increased accuracy coupled with enhanced accessibility in the overall management systems within the wide sphere of the healthcare sector. The industry is experiencing transformation due to these trends, which introduce new technologies or improve existing ones.

• Digital and Home Testing Solutions: A rising demand for digital-based means aids users who wish to conduct such tests within their homes, whereby they receive results through smartphone apps. These approaches make it easy to keep track of one's fertility even without visiting a clinic since privacy is maintained throughout this process.
• AI and Machine Learning Integration: Developing applications for artificial intelligence and machine learning in sperm count tests will make them more accurate and diagnostically capable. The AI software can assess sperm samples with greater precision, offering detailed information about sperm health as well as potential causes of infertility.
• Portable and User-Friendly Devices: Innovations in portable devices used for testing the number of sperm have made it easier for people to do so in different places. These user-friendly machines are designed to be simple, thereby reducing the need for complex laboratory tools and processes.
• Comprehensive Fertility Testing: The concept behind this approach is to integrate sperm count tests with broader fertility diagnostics. Therefore, comprehensive assessments combine sperm count analysis with other reproductive health evaluations to give a more holistic picture of fertility, thus guiding treatment choices.
• Increased Focus on Male Fertility: A deeper understanding of men's fertility is leading to improved accessibility of advanced semen analyses. Moreover, there is a drive toward improving male reproductive health, which has led to innovations targeting various areas related to fertility as well as diagnostic enhancements.

These emerging trends are transforming the landscape of sperm counting assays by increasing accessibility, accuracy, and their integration into comprehensive fertility diagnostics. Digitalization of the solutions provided, integration of AI algorithms, and user-friendly gadgets have brought convenience close to home when it comes to assessing sperm counts while emphasizing male factors leading to a general transformation in this area. In the future, these movements will be central to promoting reproductive health through better management of fertility.

Recent Developments in the Sperm Count Test Market

Recent trends in accounting for sperm count test include technological advancements that have increased accessibility and precision in diagnosis. It is an attempt to address men's inability to reproduce while providing better means for monitoring sexual productivity.

• Technological Innovations: Accordingly, new technologies are increasing the accuracy of sperm count tests with improved imaging and automation for precise, reliable results. Such inventions include high-resolution microscopy and automated semen analysis systems, whose main utility is diagnostic improvement.
• Digital Testing Solutions: Individuals can now perform tests at home using phone applications that come along with digital sperm count tests. This way of assessing fertility offers convenience as well as privacy, allowing users to check their reproductive status without necessarily having clinical visits.
• Affordable and Accessible Options: There is an ongoing effort to develop cost-effective and accessible sperm count tests, especially in underserved regions. Additionally, portable, user-friendly equipment is being designed to facilitate availability, thus making it easier for individuals to undertake these examinations.
• AI and Machine Learning: AI has been integrated into sperm count testing, improving accuracy rates as well as diagnostics. This AI-driven testing provides significant insights into the health of sperm so that fertility issues can be identified and managed effectively.
• Holistic Fertility Diagnostics: There is a trend toward combining comprehensive fertility diagnostics with serum parameters (e.g., sperm counts). This approach combines semen analysis and other diagnostic tools to give a more holistic view of fertility.

The accuracy, accessibility, and integration of diagnostic tools have greatly improved due to recent developments in sperm count test. Digital solutions, technological innovations, and AI-driven analysis are transforming the field, leading to more accurate and convenient ways of sperm count testing. Fertility management is adopting a new approach that is affordable and holistic by addressing various reproductive health needs.

Strategic Growth Opportunities for Sperm Count Test Market

Advancements in technology, increasing awareness of male fertility issues, and developing healthcare needs create several strategic growth opportunities for the sperm count test market. Taking advantage of these opportunities can lead to significant market expansion as well as improved fertility management solutions.

• Home Testing Solutions: Home-based options for counting sperm would be a great avenue for growth. This would enable companies to take advantage of an increasingly growing population seeking ways to monitor infertility without clinical visits.
• Integration with Fertility Treatments: Incorporating broader fertility treatment programs into semen volume tests offers room for further growth. When combined with other diagnostic or therapeutic services, such as sperm analysis, a comprehensive approach to managing fertility would be achieved, leading to better patient outcomes.
• AI and Automation: Utilizing artificial intelligence (AI) techniques as well as automating the processes involved in counting sperm would yield tremendous benefits. Diagnostic capacities may improve while making testing simpler, which is important for various stakeholders within the healthcare industry.
• Affordable Testing Solutions: Economic sperm count tests that are easily accessible could tap into new markets, especially in areas with limited healthcare resources. Additionally, market reach will increase by making devices portable, user-friendly, and affordably priced, thereby fulfilling unmet requirements across demographics.
• Educational and Awareness Programs: Investing in educational and awareness programs about male infertility and semen volume count poses significant potential. By increasing public knowledge and reducing the stigma around male reproductive health, testing, and related services will be in high demand.

Strategic growth opportunities in sperm count testing through home-based testing innovations, AI integration, and comprehensive fertility programs are crucial. Affordable, accessible, and educational campaigns are key to expanding market presence and addressing various reproductive health demands. These possibilities shape the future of sperm volume testing while triggering developments in fertility management.

Sperm Count Test Market Driver and Challenges

The sperm count test market is affected by several technological, economic, and regulatory factors that drive growth but also pose challenges. Therefore, understanding these drivers and challenges is a prerequisite for all stakeholders navigating the evolving landscape of reproductive health diagnostics.

Factors driving the sperm count test market include:

1. Technological Advancements: Sperm counting tests have become more accurate due to improvements in technology, especially in areas like imaging where there is high resolution or the use of artificial intelligence (AI). This leads to better diagnoses, aiding in identifying issues such as sterility, resulting in an increased number of users purchasing them, and driving market expansion.

2. Growing Awareness of Male Fertility: The increase in awareness surrounding male infertility explains why individuals are demanding a higher frequency of sperm count checks. Additionally, the need for advanced solutions for checking this condition has risen due to a greater focus on male reproductive health by both patients and medical professionals, thus fueling market expansion.

3. Home Testing Solutions: The use of home-based platforms is currently boosting sales of male fertility test kits that can be used in the privacy of homes. These products provide an alternative to clinical monitoring of fertility, which many individuals wish to avoid.

4. Integration with Fertility Treatments: This approach has made it possible for several issues regarding diagnosis and therapy to be addressed by sperm count tests as part of extensive infertility treatment programs. This has driven market demand for sophisticated diagnostic solutions that consider fertility holistically.

5. Investment in Research and Development: Increased funding for research and development continues to contribute to innovations in the sphere of sperm count testing techniques. This results in more expenditure on R&D, leading to rapid progress and better methods of analyzing sperm count levels across various populations globally.

Challenges in the sperm count test market include:

1. High Costs of Advanced Testing: Cost is a significant factor affecting the adoption rates for complex forms of sperm counting technologies, such as IVF procedure kits or PCRs. Underdeveloped countries may have limited access due to unaffordable equipment and chemicals, thus impeding market penetration.

2. Regulatory Hurdles: Product approval may be affected by different regional regulatory frameworks and requirements applicable to medical devices, including diagnostic test products. Compliance with diverse standards may delay product launch, registration, or regulatory clearance, depending on the regions in which they are intended to operate.

3. Technological Integration Issues: There may also be bottlenecks in integrating advanced systems for counting sperm with existing ones. Compatibility challenges, combined with special training requirements, can make it difficult for medical professionals involved in such procedures to adopt them.

The main factors driving and inhibiting the sperm count testing market reflect an evolving environment shaped by technological advancements, growing awareness, and regulatory intricacies. Innovations and focus on male fertility rates are leading to increased sales, while issues around cost, legal requirements, and economic downturns hinder growth. Consequently, addressing these challenges while capitalizing on enablers is important for industry players to thrive in this changing landscape toward improved reproductive health.

List of Sperm Count Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies sperm count test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the sperm count test companies profiled in this report include-

• AB ANALITICA
• Artron Laboratories
• Bioline Technologies
• CooperSurgical
• Diacron International
• DNA Diagnostics Center
• ExSeed Health
• Hamilton Thorne
• Medical Electronic Systems
• Microptic

Sperm Count Test by Segment

The study includes a forecast for the global sperm count test market by technique, age group, end use, and region.

Sperm Count Test Market by Technique [Analysis by Value from 2019 to 2031]:

• Chromatographic Immunoassay & Colorimetric Reaction
• Microscopy
• Smartphone-Based
• Others

Sperm Count Test Market by Age Group [Analysis by Value from 2019 to 2031]:

• 34 and Below 34 Years
• 35-40 Years
• 41 Years and Above

Sperm Count Test Market by End Use [Analysis by Value from 2019 to 2031]:

• Fertility Centers
• Hospitals & Clinics
• Diagnostic Laboratories
• Others

Sperm Count Test Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Sperm Count Test Market

The global landscape of sperm count tests has undergone a paradigm shift due to technological advancements, increasing awareness of male fertility issues, and dynamic health needs. The latest developments are diverse and characterized by various approaches in different countries, addressing aspects of sperm count estimation such as accuracy, accessibility, and compatibility with wider fertility therapy efforts. These changes signify an emerging need to improve diagnostic precision toward individualization of diagnosis and provision.

• United States: In the USA, recent advances in sperm count testing incorporate digital technology and improve home-testing options. Modern devices for analyzing sperm now come with findings generated through smartphone applications using real-time methods. These include increased accuracy levels through AI analysis as well as better user interfaces that enhance ease of use. The goal is to make it more convenient for individuals who wish to privately monitor their fertility status.
• China: Significant progress in this field has been achieved through sophisticated laboratory technologies and research funding. This includes high-resolution imaging techniques and automated semen analysis systems aimed at improving the fidelity of test results. Moreover, there is a rising trend toward integrating sperm count testing into broader infertility treatment programs, indicating a more holistic approach to addressing infertility.
• Germany: What distinguishes Germany's progress on this subject is its focus on precision and standardization. German researchers lead in developing advanced diagnostic tools that offer high degrees of precision and reproducibility. Recent trends include the use of innovative biomarker assays alongside automated systems for analyzing sperm. Germany also aims to include a comprehensive approach to male fertility diagnostics in its services.
• India: Recent developments in India regarding sperm count testing revolve around affordability and accessibility improvements. Efforts are being made to develop cost-effective and user-friendly sperm count tests that can be utilized in both urban and rural areas. Additionally, novel developments such as portable testing devices and community-based health programs enhance awareness and access to sperm analysis services, expanding the scope of testing to address the growing concerns about male fertility.
• Japan: Technological advancements in Japan concerning sperm count testing aim to improve diagnostic precision using advanced methods. Japanese scientists are developing high-tech gadgets for evaluating semen quality through artificial intelligence and machine learning. A growing focus is also on incorporating sperm count tests into broader fertility treatment frameworks, streamlining diagnosis through new diagnostic tools and simplified testing methods.

Features of the Global Sperm Count Test Market

Market Size Estimates: Sperm count test market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Sperm count test market size by technique, age group, end use, and region in terms of value ($B).

Regional Analysis: Sperm count test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different techniques, age groups, end uses, and regions for the sperm count test market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the sperm count test market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the sperm count test market by technique (chromatographic immunoassay & colorimetric reaction, microscopy, smartphone-based, and others), age group (34 and below 34 years, 35-40 years, and 41 years and above), end use (fertility centers, hospitals & clinics, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Sperm Count Test Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Sperm Count Test Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Sperm Count Test Market by Technique
  • 3.3.1: Chromatographic Immunoassay & Colorimetric Reaction
  • 3.3.2: Microscopy
  • 3.3.3: Smartphone-Based
  • 3.3.4: Others
• 3.4: Global Sperm Count Test Market by Age Group
  • 3.4.1: 34 and Below 34 Years
  • 3.4.2: 35-40 Years
  • 3.4.3: 41 Years and Above
• 3.5: Global Sperm Count Test Market by End Use
  • 3.5.1: Fertility Centers
  • 3.5.2: Hospitals & Clinics
  • 3.5.3: Diagnostic Laboratories
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Sperm Count Test Market by Region
• 4.2: North American Sperm Count Test Market
  • 4.2.1: North American Sperm Count Test Market by Technique: Chromatographic Immunoassay & Colorimetric Reaction, Microscopy, Smartphone-Based, and Others
  • 4.2.2: North American Sperm Count Test Market by End Use: Fertility Centers, Hospitals & Clinics, Diagnostic Laboratories, and Others
• 4.3: European Sperm Count Test Market
  • 4.3.1: European Sperm Count Test Market by Technique: Chromatographic Immunoassay & Colorimetric Reaction, Microscopy, Smartphone-Based, and Others
  • 4.3.2: European Sperm Count Test Market by End Use: Fertility Centers, Hospitals & Clinics, Diagnostic Laboratories, and Others
• 4.4: APAC Sperm Count Test Market
  • 4.4.1: APAC Sperm Count Test Market by Technique: Chromatographic Immunoassay & Colorimetric Reaction, Microscopy, Smartphone-Based, and Others
  • 4.4.2: APAC Sperm Count Test Market by End Use: Fertility Centers, Hospitals & Clinics, Diagnostic Laboratories, and Others
• 4.5: ROW Sperm Count Test Market
  • 4.5.1: ROW Sperm Count Test Market by Technique: Chromatographic Immunoassay & Colorimetric Reaction, Microscopy, Smartphone-Based, and Others
  • 4.5.2: ROW Sperm Count Test Market by End Use: Fertility Centers, Hospitals & Clinics, Diagnostic Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Sperm Count Test Market by Technique
  • 6.1.2: Growth Opportunities for the Global Sperm Count Test Market by Age Group
  • 6.1.3: Growth Opportunities for the Global Sperm Count Test Market by End Use
  • 6.1.4: Growth Opportunities for the Global Sperm Count Test Market by Region
• 6.2: Emerging Trends in the Global Sperm Count Test Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Sperm Count Test Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Sperm Count Test Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: AB ANALITICA
• 7.2: Artron Laboratories
• 7.3: Bioline Technologies
• 7.4: CooperSurgical
• 7.5: Diacron International
• 7.6: DNA Diagnostics Center
• 7.7: ExSeed Health
• 7.8: Hamilton Thorne
• 7.9: Medical Electronic Systems
• 7.10: Microptic